(Q33431322)

26 July 2017

1 reference

title

Role of steroids in the management of diabetic macular edema and proliferative diabetic retinopathy (English)

1 reference

proliferative diabetic retinopathy

26 July 2017

1 reference

diabetic macular edema

1 reference

based on heuristic

inferred from title

1 reference

Paolo S Silva

1

1 reference

26 July 2017

Jennifer K Sun

series ordinal

2

1 reference

26 July 2017

Lloyd Paul Aiello

series ordinal

3

1 reference

26 July 2017

language of work or name

English

0 references

publication date

1 March 2009

1 reference

Seminars in Ophthalmology

26 July 2017

1 reference

26 July 2017

24

1 reference

26 July 2017

2

1 reference

26 July 2017

93-99

1 reference

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

26 July 2017

1 reference

https://api.crossref.org/works/10.1080%2F08820530902800355

The prevalence of diabetic retinopathy among adults in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820530902800355

The long-term effects of laser photocoagulation treatment in patients with diabetic retinopathy: the early treatment diabetic retinopathy follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820530902800355

Macular edema. A complication of diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820530902800355

A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820530902800355

Diabetic macular edema: what is focal and what is diffuse?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820530902800355

Diurnal variation in retinal thickening measurement by optical coherence tomography in center-involved diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820530902800355

Pathophysiology of diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820530902800355

Systemic considerations in the management of diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820530902800355

Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820530902800355

Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820530902800355

Nonenzymatic glycosylation and the pathogenesis of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820530902800355

Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820530902800355

Intravitreal triamcinolone acetonide for treatment of intraocular proliferative, exudative, and neovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820530902800355

A possible mechanism for inhibition of angiogenesis by angiostatic steroids: induction of capillary basement membrane dissolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820530902800355

Angiostatic steroids. Method of discovery and mechanism of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820530902800355

Mechanism of action of the angiostatic cortisene anecortave acetate

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820530902800355

Anecortave acetate as monotherapy for the treatment of subfoveal lesions in patients with exudative age-related macular degeneration (AMD): interim (month 6) analysis of clinical safety and efficacy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820530902800355

Anecortave acetate (15 milligrams) versus photodynamic therapy for treatment of subfoveal neovascularization in age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820530902800355

Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820530902800355

Intravitreal triamcinolone for refractory diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820530902800355

Intravitreal triamcinolone versus laser photocoagulation for persistent diabetic macular oedema

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820530902800355

Intravitreal triamcinolone acetonide for diabetic diffuse macular edema: preliminary results of a prospective controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820530902800355

Intravitreal triamcinolone for refractory diabetic macular edema: two-year results of a double-masked, placebo-controlled, randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820530902800355

Intravitreal triamcinolone acetonide for diffuse diabetic macular oedema: 6-month results of a prospective controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820530902800355

Randomized trial of peribulbar triamcinolone acetonide with and without focal photocoagulation for mild diabetic macular edema: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820530902800355

Intravitreal bevacizumab (avastin) injection alone or combined with triamcinolone versus macular photocoagulation as primary treatment of diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820530902800355

Intravitreal bevacizumab with or without triamcinolone for refractory diabetic macular edema; a placebo-controlled, randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820530902800355

Intravitreal triamcinolone plus sequential grid laser versus triamcinolone or laser alone for treating diabetic macular edema: six-month outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820530902800355

Intravitreal triamcinolone compared with macular laser grid photocoagulation for the treatment of cystoid macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820530902800355

Macular grid photocoagulation after intravitreal triamcinolone acetonide for diffuse diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820530902800355

Treatment with intravitreal steroid reduces blood-retinal barrier breakdown due to retinal photocoagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820530902800355

Panretinal photocoagulation and intravitreal triamcinolone acetonide for the management of proliferative diabetic retinopathy with macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820530902800355

Triamcinolone as adjunctive treatment to laser panretinal photocoagulation for proliferative diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820530902800355

Intravitreal triamcinolone as an adjunct in the treatment of concomitant proliferative diabetic retinopathy and diffuse diabetic macular oedema. Combined IVTA and laser treatment for PDR with CSMO.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820530902800355

Laser photocoagulation combined with intravitreal triamcinolone acetonide injection in proliferative diabetic retinopathy with macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820530902800355

Combined laser and intravitreal triamcinolone for proliferative diabetic retinopathy and macular edema: one-year results of a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820530902800355

10.1080/08820530902800355

21 January 2018

Identifiers

DOI

1 reference

26 July 2017

1 reference